IFNB1 and glioblastoma: A limitation of therapeutic studies with human IFN‐β in xenograft GBM models is that they have to be conducted in immuno‐deficient athymic nude mice where human IFN‐β does not interact with mouse IFN‐β receptors (Harari et al., 2014).